Clinically tested during pregnancy, improves glycemic parameters in women with gestational diabetes
CLINICALLY TESTED
Learn more about clinical studies:
Femininity in balance
Egregia®
& Gonalia®
Safe and effective solutions for a personalized treatment plan
Egregia
for women with PCOS Dismetabolic
Phenotype
Gonalia
for women with PCOS Hyperandrogenic
Phenotype
Egregia & Gonalia
Innovative Formula Nutraceuticals to Support Women with PCOS
Tailored and Innovative Solutions for Effective Management of Metabolic and Hyperandrogenic Profiles in PCOS. Targeted Formulations Address the Unique Needs of Each Profile.
- Developed with innovative technologies
- Unique formulations with high absorption and prolonged release over time
- Targeted and specific components to address metabolic syndrome or hyperandrogenism
- Preclinical and Clinical Studies in Support
When to use Egregia
PCOS is often associated with metabolic disorders, including obesity, central and abdominal fat, insulin resistance, and cardiovascular risk factors. EGREGIA contains 3 different forms of RESVERATROL, which guarantee prolonged absorption over time. RESVERATROL acts on multiple levels, playing an important role in COUNTERACTING:
Insulin Resistance and Metabolic Manifestations in PCOS
- To support energy metabolism (Magnesium)
- For Menstrual Cycle Irregularities (Vitamin B6)
In Pregnant Women with Gestational Diabetes
(Biondelliet all.)
By virtue of its components' effects on the neuroendocrine axis, GONALIA intervenes in the pathophysiology of PCOS by counteracting reproductive alterations and clinical signs due to Hyperandrogenism associated with PCOS.
- As a Support for Hyperandrogenic Manifestations in PCOS
- For menstrual cycle irregularities and disorders (Vitamin B6)
- Also supports hypothalamic Amenorrhea (Vitamin B6)
- Helpful Support for Acne and Hirsutism (Teupoloside)
How to use Egregia
The recommended daily dose is to take two tablets per day for 15 days, and then one tablet per day thereafter, away from meals.
How to use Gonalia
The recommended daily dose is to take two tablets per day for 15 days, and then one tablet per day thereafter, away from meals.
Beneficial effects are noticeable with continuous use of the product for at least 3 months, which may be extended according to the recommendation of the medic.
The innovative patented formulations of EGREGIA and GONALIA represent a therapeutic opportunity for personalized treatment of PCOS